InvestorsHub Logo

hoffmann6383

08/15/22 11:11 AM

#505134 RE: Poor Man - #505126

The C shares weren't used for some crazy purpose. A very small bunch of shares were used to fund ongoing operations while saving as many as possible for a later date when the share price is higher. This is exactly what common sense tells you was going to happen it is happening exactly as I predicted back on 7-29.

CrashOverride

08/15/22 11:24 AM

#505141 RE: Poor Man - #505126

My response to Les this morning regarding the C subscription agreement which I received last Friday:

"It was great speaking with Les last week. Thank you for taking the time. I have decided to hold off on further investments in Northwest Biotherapeutics until I can read more about the landmark trial results in a journal article. Hopefully this will be forthcoming."

Peer review can take 3-6 months so we are still within the range assuming submission was right before NYAS 5/10.

biosectinvestor

08/15/22 12:25 PM

#505154 RE: Poor Man - #505126

What, that they are finding their commercial manufacturing and application process? Doesn’t seem like it deflated anything to me. This is August doldrums.

This stock started the year at .70, and went up .07 on the first trading day of the year. We’re at .62 while in the doldrums of August, and after the rest of the market tanked as interest rates have gone up in 2022. Hardly earth shattering.